Studies documented that oral butyrate supplementation in patients with IBD activated epithelial peroxisome proliferator-activated receptor-γ (PPAR-γ) signaling and promoted generation of Treg cells in colonic lamina propria [38]. The gene discussed is PPARG; the disease is inflammatory bowel disease.